Tag: Plasmid-Based Cancer Immunotherapy
OncoSec announces first subjects dosed in Phase 1 trial of COVID-19...
OncoSec Medical Inc has announced that it has dosed several subjects in its Phase 1 clinical trial of CORVax12.
According to the company, it is...
